Ownership history in nVerses Capital, LLC · 7 quarters on record
This page tracks every 13F SEC filing in which nVerses Capital, LLC reported a position in ITEOS THERAPEUTICS INC (ITOS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | UNCHANGED | 2,500 | — | 0% | 0.01% | $26K | — |
| 2025 Q2 | UNCHANGED | 2,500 | — | 0% | 0.01% | $26K | — |
| 2025 Q1 | UNCHANGED | 2,500 | — | 0% | 0.01% | $26K | — |
| 2024 Q4 | UNCHANGED | 2,500 | — | 0% | 0.01% | $26K | — |
| 2024 Q3 | ADDED | 2,500 | +1,700 | +212.5% | 0.01% | $26K | — |
| 2024 Q2 | ADDED | 800 | +300 | +60.0% | 0.01% | $12K | — |
| 2024 Q1 | INITIATED | 500 | — | — | 0.02% | $7K | — |